(68)Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin. (Q48860405)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

(68)Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Mónica Rodríguez-Taroco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Eduardo Savio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Cecilia Bentancourt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Juan P Gambini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Henry Engler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

27 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

Annals of Nuclear Medicine

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

638-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12149-014-0856-3

19 March 2020

exact match

0 references

cites work

Cancer of unknown primary site

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Pathologic evaluation of unknown primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Contemporary nuclear medicine imaging of neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-014-0856-3

10.1007/S12149-014-0856-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24862238%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference